2026-04-13T05:55:24Zhttps://recercat.cat/oai/request
oai:recercat.cat:2072/4704772025-10-07T13:36:13Zcom_2072_98col_2072_378192
RECERCAT author Abumayyaleh, Mohammad author Nuñez-Gil, Ivan Javier author Viana-LLamas, María C. author Raposeiras-Roubin, Sergio author Romero, Rodolfo author Alfonso-Rodríguez, Emilio author Uribarri, Aitor author Feltes, Gisela author Becerra-Muñoz, Víctor Manuel author Santoro, Francesco author Pepe, Martino author Castro Mejía, Alex Fernando author Signes-Costa, Jaime author Gonzalez, Adelina author Marín, Francisco author López-País, Javier author Manzone, Edoardo author Vazquez Cancela, Olalla author Paeres, Carolina Espejo author Masjuan, Alvaro López author Velicki, Lazar author Weiß, Christel author Chipayo, David author Fernandez-Ortiz, Antonio author El-Battrawy, Ibrahim author Akin, Ibrahim author Universitat Autònoma de Barcelona 2023 Diabetes mellitus (DM) is one of the most frequent comorbidities in patients suffering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a higher rate of severe course of coronavirus disease (COVID-19). However, data about post-COVID-19 syndrome (PCS) in patients with DM are limited. This multicenter, propensity score-matched study compared long-term follow-up data about cardiovascular, neuropsychiatric, respiratory, gastrointestinal, and other symptoms in 8,719 patients with DM to those without DM. The 1:1 propensity score matching (PSM) according to age and sex resulted in 1,548 matched pairs. Diabetics and nondiabetics had a mean age of 72.6 ± 12.7 years old. At follow-up, cardiovascular symptoms such as dyspnea and increased resting heart rate occurred less in patients with DM (13.2% vs. 16.4%; p = 0.01) than those without DM (2.8% vs. 5.6%; p = 0.05), respectively. The incidence of newly diagnosed arterial hypertension was slightly lower in DM patients as compared to non-DM patients (0.5% vs. 1.6%; p = 0.18). Abnormal spirometry was observed more in patients with DM than those without DM (18.8% vs. 13; p = 0.24). Paranoia was diagnosed more frequently in patients with DM than in non-DM patients at follow-up time (4% vs. 1.2%; p = 0.009). The incidence of newly diagnosed renal insufficiency was higher in patients suffering from DM as compared to patients without DM (4.8% vs. 2.6%; p = 0.09). The rate of readmission was comparable in patients with and without DM (19.7% vs. 18.3%; p = 0.61). The reinfection rate with COVID-19 was comparable in both groups (2.9% in diabetics vs. 2.3% in nondiabetics; p = 0.55). Long-term mortality was higher in DM patients than in non-DM patients (33.9% vs. 29.1%; p = 0.005). The mortality rate was higher in patients with DM type II as compared to those without DM. Readmission and reinfection rates with COVID-19 were comparable in both groups. The incidence of cardiovascular symptoms was higher in patients without DM. open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. https://creativecommons.org/licenses/by/4.0/ Diabetes mellitus Post-covid-19 syndrome SARS-CoV-2 Respiratory complications Reinfection Vaccination rate Long-term mortality Post-COVID-19 syndrome and diabetes mellitus : a propensity-matched analysis of the International HOPE-II COVID-19 Registry Article